rs775783026
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 9P and 4B. PVS1PP5BS2
The NM_004655.4(AXIN2):c.1201-2A>G variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00000711 in 1,547,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004655.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- oligodontia-cancer predisposition syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- tooth agenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- craniosynostosisInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004655.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AXIN2 | NM_004655.4 | MANE Select | c.1201-2A>G | splice_acceptor intron | N/A | NP_004646.3 | |||
| AXIN2 | NM_001363813.1 | c.1201-2A>G | splice_acceptor intron | N/A | NP_001350742.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AXIN2 | ENST00000307078.10 | TSL:1 MANE Select | c.1201-2A>G | splice_acceptor intron | N/A | ENSP00000302625.5 | |||
| AXIN2 | ENST00000375702.5 | TSL:1 | c.1201-2A>G | splice_acceptor intron | N/A | ENSP00000364854.5 | |||
| AXIN2 | ENST00000618960.4 | TSL:5 | c.1201-2A>G | splice_acceptor intron | N/A | ENSP00000478916.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152026Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000590 AC: 1AN: 169426 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000645 AC: 9AN: 1395810Hom.: 0 Cov.: 36 AF XY: 0.00000437 AC XY: 3AN XY: 687130 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152026Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74228 show subpopulations
ClinVar
Submissions by phenotype
Oligodontia-cancer predisposition syndrome Pathogenic:2Uncertain:1
This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function.
This sequence change affects an acceptor splice site in intron 5 of the AXIN2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in AXIN2 are known to be pathogenic (PMID: 15042511, 21416598). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with AXIN2-related conditions. ClinVar contains an entry for this variant (Variation ID: 464525). Studies have shown that disruption of this splice site is associated with altered splicing resulting in multiple RNA products (internal data). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Colorectal cancer Pathogenic:1
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1201-2A>G intronic variant results from an A to G substitution two nucleotides upstream from coding exon 5 in the AXIN2 gene. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site and may result in the creation or strengthening of a novel splice acceptor site; however, direct evidence is insufficient at this time (Ambry internal data). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic.
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); Canonical splice site variant with an unclear effect on protein function and both splice predictors and evolutionary conservation support a deleterious effect, although in the absence of functional evidence the actual effect of this sequence change is unknown.; Observed in an individual with glioblastoma (Huang 2018); This variant is associated with the following publications: (PMID: 29625052)
AXIN2-related attenuated familial adenomatous polyposis Other:1
Variant interpreted as Likely pathogenic and reported on 01-10-2020 by Lab or GTR ID 61756. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at